Dr Reddy’s Laboratories has expanded its portfolio of generic semaglutide medicines in India with two new brands, Obeda Pro and Obeda Plus, following supply disruptions affecting its original Obeda injection. The new products are manufactured by Hetero Labs, while the original injectable was produced by OneSource Specialty Pharma. Distributors told Reuters that the company Continue Reading
